Tilray | TRLY - Attività Correnti





Attività Correnti Cambiamento Data
Acasti Pharma USD 14.33M 4.88M 2026-06
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alaunos Therapeutics USD 666K 304K 2026-06
Aurora Cannabis CAD 393.45M 4M 2026-06
Avita Medical AUD 28.39M 7.1M 2026-06
Canopy Growth CAD 506.36M 23.1M 2026-06
Cronos Group USD 912.03M 15.85M 2026-06
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Divis Laboratories Ltd INR 110.96B 12.53B 2026-03
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
IQVIA Holdings USD 6.45B 225M 2026-09
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Moderna USD 5.82B 45M 2026-06
Organigram Holdings CAD 280.09M 30M 2026-06
Organon & Co USD 5.37B 258M 2026-09
Revvity USD 2.3B 169.4M 2026-06
Tectonic Therapeutic USD 231.1M 8.79M 2026-06
Tilray USD 729.32M 28.18M 2025-09
Viatris USD 10.06B 861.1M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zealand Pharma A/S 15.02B 652.12M 2026-03